3A3188).
Introduction
Epidermal growth factor (EGF) is present in human placental trophoblasts throughout pregnancy, as well as in gestational decidua (1). as is transforming growth factor-a, the postulated analogue of EGF in the fetus (2,3). Both growth factors bind and exert their effects through the EGF receptor, which is a tyrosine kinase receptor involved in regulation of cell growth and differentiation (4). and EGF receptor mRNA levels increase with gestational age (9). Therefore, it has been hypothesized that the EGFreceptor interaction initiates a series of events that are in part responsible for growth and differentiation of the trophoblast as well as for regulation of its differentiated function. EGF stimulates the release of human placental lactogen (6,lO-11). human chorionic gonadotropin (hCG) (11-16). and progesterone (17) by cultured normal human placental cells (6, lO-13) and by choriocarcinoma cell lines (12, 14, 15) .
Three studies have examined the tissue disuibution of EGF receptors in human placental trophoblast using monoclonal antibodies (MAb) to the human EGF receptor (18) (19) (20) , one of which was to little to no staining of either trophoblast cell layer but intense staining of fetal connective tissue cells. Staining for EGF receptors over cytotrophoblasts in the fmt trimester is consistent with the hypothesis that maternal EGF or 'EF-a derived from the endometrium or placenta may be the mitogen respoasible for cytotrophoblast cell division and that the receptors localized to the syncytiotrophoblast are involved in EGF regulation of differentiated function. The absence of heavy staining of activated EGF receptor on trophoblast plasma membranes in third-trimester placentas is consistent with down-regulation of EGF receptor activity. Cytochem &: [907] [908] [909] [910] [911] [912] [913] [914] [915] 1994) the EGF binding domain of the receptor (MAb 528) (18) . In the study by Kawagoe et al. (18) . intense staining of the binding domain of the EGF receptor was demonstrated on the microvillous border of the syncytiotrophoblast facing the maternal blood in the intervillous space. Although the cytotrophoblast cell surface adjacent to the syncytiotrophoblast was shown to stain, the cytotrophoblast plasma membrane domain adjacent to the basal lamina stained very weakly or not at all.
The study reported here is unique inasmuch as the pattem and distribution of staining of the human EGF receptor binding domain was compared to the staining of the activated (tyrosinephosphorylated) human EGF receptor in first-and third-trimester human placental tissues. Establishing the distribution of EGF receptors relative to the trophoblast and decidual sources ofEGF (1) and E K a (2,3) is important in elucidating whether EGF regulation of placental hormone secretion is the result of an autocrine, paracrine, or endocrine interaction. This information will in tum provide information relevant to the study of placental-uterine interactions required for implantation, placental growth, and Srentiated hormone secretion. were used in this study. MAb 528 inhibits binding ofEGF to the EGF receptor in human A431 epidermoid carcinoma cells (A431) and is an antagonist of EGF-stimulated protein-tyrosine kinase activity (21) (22) (23) . The tyrosinephosphorylated human EGF receptor was used as the immunogen for the production ofthe commercially available MAb to the activated human EGF receptor. Western blot analyses of human A431 cell membranes were carried out to demonstrate the presence ofthe EGF receptor binding domain using MAb 528 and to demonstrate endogenously phosphorylated EGF receptors using the antibody to the activated receptor. Thereafter, Western blot analyses of purified A431 EGF receptors were undertaken to venfy the selectivity of the antibody to the activated EGF receptor compared with the unactivated EGF receptor.
Materials and Methods
Detergent-free homogenates of human A431 cells were used as the source of membrane, rather than placental tissue, owing to the abundance of EGF receptors and the large body of data available (5). In a separate experiment, purified EGF receptor was prepared from Triton X-100-solubilized cells by immunoaffinity chromatography using MAb 528 linked to Sepharose 4B with competitive elution by EGF (UBI; Lake Placid, NY) as previously described (22.23) . Membrane EGF receptors were activated with l pM EGF for 20 min at room temperature (RT) before addition of the kinase reaction mixture, whereas purified EGF receptor had been pre-saturated with EGF during the purification procedure (22) . The kinase reaction mixture contained 20 mM HEPES, pH 7.4, 2 mM MnC12, 5 mM MgClz, 10 NM Na3V04, 10 pM leupeptin, 0.01 trypsin inhibition units of aprotinin/ml in the presence or absence of 10 pM ATP (all from Sigma; St Louis, MO).
The reactions were allowed to proceed for 5 min at 4'C, and were then stopped by addition of SDS-PAGE sample buffer (4% SDS, 0.4 M glycine, 20% glycerol, 50 mM Tris base, pH 8.3, nd 0.1% bromophenol blue). Nonreducing SDS-PAGE was performed in 7.5% acrylamide gels using 26 pg of membrane protein or 0.75 pg pure EGF receptor per lane. The proteins were transferred to Immobilon-P FVDF membranes (0.45 pm) (Millipore; Bedford, MA) and electroeluted for 1 hr at 120 V and 350 to 400 mA. PVDF membranes were rinsed once with Tris-buffered saline containing Tween 20 (TBST; 10 mM Tris-HCI, pH 8, 150 mM NaCI, 0.05% Twnn 20) and blocked overnight in TBST with 0.25% gelatin (TBSTG). The membrane was then incubated with either MAb 528 (500 nglml) or the MAb to the activated EGF receptor (500 nglml) for 2 hr at RT. The membranes were then washed four times in TBSTG and probed with sheep anti-mouse IgG (H+L) conjugated to peroxidax (1:lOOO) (Sigma) diluted in TBST. The site of antibody binding was visualized with an ECL Westcm chemiluminescence detection system (Amersham; Arlington Heights, IL) followed by lumigraphy. As controls, membrane and purified EGF receptors were also assayed in the presence of[y-32P]-ATP (6.5 x lo6 cpmlpmol) and the reaction mixture noted a h , using SDS-PAGE followed by autoradiography to document the autophosphorylation of the EGF receptor.
I " u n o q " i c a l SPining. For immunoperoxidax staining, deparaffinized placental sections were incubated sequentially in the following solutions: (a) PBS/l% gelatin, pH 7.3, 10 min at RT to block nonspecific sites; (b) mouse MAb to the EGF binding domain ofthe human EGF receptor (MAb 528, 10 pg/ml) (21) (22) (23) or to the activated (tyrosine-phosphorylated) EGF receptor (10 pglml), 18 hr, 4'C; (c) 0.3% H202 in PBS for 30 min at RT (d) biotinylated horse anti-mouse IgG (Vector; Burlingame, CA), 1 pglml, 4 hr, 4'C (e) avidin-peroxidase (Vector), 10 pg/ml, 4 hr, 4°C ;
and (f) peroxidax substrate mixture: 3,Y-diaminobenzidine teuahydrochloride, 0.3 mg/ml (Polysciences; Wmington, PA) and 0.05% HzOz in 0.05 M Tiis buffer, pH 7.6, 2-10 min, RT. In separate experiments, Steps b and c were reversed to examine the dfect of HzOz treatment on the subsequent binding of the EGF receptor antibodies. For staining using alkaline phosphatase as a marker, Step c was omitted and the following substitutions were made: (e) avidin-calfalkaline phosphatase (Vector), 5 Ulml, 4 hr, 4'C and (f) alkaline phosphatase substrates (Vector 111 kititlblue; Vector) containing levamisole to inactivate endogenous M i n e phosphatases. All slides were viewed under a microscope during immunostaining. The reaction was terminated by dilution in PBS when diffuse background staining began to increase at a greater rate than staining of specific placental cells. Extensive measures were taken to optimize the staining with both MAb to make valid comparisons of the pattern ofstaining. Each MAb was titrated to determine the concentration providing the optimal signal-to-noise ratio and the biotin-avidin-enzymc detection system was employed to provide the greatest amplification of the signal.
Method controls consisted of deletion of the MAb to the binding domain or to the activated EGF receptor, or deletion ofthe biotinylated horse anti-mouse IgG. To determine the specificity of the immunostaining, MAb 528 (0.5 nM) was pre-absorbed with human EGF receptor isolated from A431 cells (50 nM) (21) for 24 hr at 4'C before use. Control sections were immunostained for the same length of time as the adjacent experimental sections. All slides were vi& and photographed with a Nikon photomicroscope (Fryer Company; Huntley, IL). 
Results

Immunostaining of First-trimester Placental Tissues
Immunostaining of first-trimester placental tissues with antibodies to the binding domain of the human EGF receptor revealed staining of both the cytotrophoblast and the syncytiotrophoblast cell layers of placental villi (Figures 1, A, 2, and 3) . Staining of the cells of the cytotrophoblast, which undergo cell division and give rise to the syncytiotrophoblast, ranged from no staining (Figure 1 (Figures 1, B, and 2 ) to intense staining of both the syncytiotrophoblast cytoplasm and the microvillous border ( Figure 3 ). The nuclei of both epithelial layers were unstained. The cytoplasm of the fetal connective tissue cells forming the core of the villi showed various degrees of positive staining, ranging from light (Figure 2 ) to moderate staining ( Figure 3 ). Three general patterns of trophoblast staining in first-trimester placental tissues were noted. First, in portions of first-trimester villi, the cells of both the cytotrophoblast and the syncytiotrophoblast stained for the EGF binding domain of the EGF receptor (Figure  1, A) . Second, in the same or adjacent villi, areas were seen with little or no immunostaining of the cytotrophoblast cells but intense staining of the microvillous border of the syncytiotrophoblast (Figure 1, B) . Third, the cells of the cytotrophoblast immunostained but the syncytiotrophoblast did not (Figure 1, C) . Note the abrupt transition from one staining pattem to another indicated by the arrow. This change in staining pattern of the syncytiotrophoblast is also evident in Figure 3 . The different patterns did not appear to correlate with whether the villi were primary, secondary, or tertiary villi as judged by cross-sectional area.
Staining of adjacent sections of 7-week human placental tissue with the MAb either to the EGF receptor binding domain ( Figure  3) or to the activated EGF receptor (Figure 4 ) demonstrated similar patterns of staining, with the notable exception of the absence of staining of activated EGF receptor over the cytotrophoblast and syncytiotrophoblast plasma membranes. Figure 3 shows light to intense staining of both the cytoplasm and microvillous border of a portion of the syncytiotrophoblasts ofthis 7-week human placental tissue (open arrows) with MAb 528 to the EGF receptor binding domain. In this sample, the cytotrophoblasts are essentially unstained (solid arrows). Immunostaining with the MAb to the activated EGF receptor resulted in a similar staining pattern (solid and open arrows), although less intense (Figure 4 ).
Immunostaining of Third-trimester Placental Tissues
Immunostaining of term placenta sections with the antibody to the binding domain of the EGF receptor (528) and the antibody to the activated EGF receptor are shown in Figures 5-7 . The pattern of staining with the antibody to the binding domain of the EGF receptor differed from that of first-trimester placentas, in that there was little to no staining of the syncytiotrophoblast cytoplasm or the microvillous boundary facing matemal blood (Figure 7 , closed arrows) but there was intense staining of the fetal connective tissue (Figures 5 and 7) . Staining was occasionally observed in the plane of the cytotrophoblast cell layer, its reduced dimensions reflecting the absence of significant growth of the placental mass in the third trimester (Figure 7 , open arrows). The solid arrows in Figure 7 indicate the matemal face of the syncytiotrophoblast, which appears as an unstained halo surrounding the cytotrophoblasts and subjacent connective tissue core. When term placenta was immunostained with MAb 528 that had been pre-absorbed with a tenfold excess of purified EGF receptors isolated from A431 cells, staining of the cytotrophoblasts and the cellular components of fetal connective tissue was greatly diminished (BO%) or abolished (contrast Figures  7 and 8 ) .
Staining of adjacent sections of placental tissue with the MAb to the binding domain of the EGF receptor (Figure 5 ) or to the activated EGF receptor ( Figure 6 ) revealed little to no staining of the cytotrophoblast or syncytiotrophoblast cell layers in either sample. However, there was distinct, intense staining of fetal connec- Figure 5 intense staining of fetal connective tissue of the smaller villi is shown, but faint staining of the connective tissue surrounding the large blood vessel (asterisk). In Figure 6 there is intense staining of all fetal connective tissue, including that surrounding the large blood vessel (asterisk).
Validation of Antibody Receptor Specz9city by Western Blot Analyses
Western blot analyses were carried out to document the specificity of the MAb for the human EGF receptor binding domain and for the activated form ofthe receptor. Figure 9 shows immunostaining of A431 membranes with the anti-EGF receptor binding domain antibody (MAb 528) under unstimulated conditions, in the presence of EGF, and in the presence of both EGF and All? Under each condition, A431 membranes showed an intense band at -170 KD, the size of the EGF receptor. When the purified EGF receptor preparation was treated with EGF, a band of -170 KD was also evident (22) (Figure 9 ). However, when ATP was added to the tyrosine kinase reaction mixture, a band of 175-180 KD MW was seen; the molecular weight shift probably reflects the increased phosphorylation of the purified EGF receptor. The 100 KD band seen in both the membrane and purified receptor preparations presumably represents degraded EGF receptor. Incorporation of [ 32P]-ATP demonstrated that several membranes proteins were phosphorylated, but only the phosphorylated EGF receptor was detected in the purified receptor preparation with hfAb 528 (data not shown).
Similarly, Figure 10 shows hmunostaining of A431 membranes or purified EGF receptor with the MAb to the activated (tyrosinephosphotylated) receptor. The A431 membrane preparation shows a light band under untreated or EGFstimulated conditions. However, a more intense band is seen with the preparation treated with both EGF and ATP, i.e., under conditions that promote EGF receptor self-phosphorylation. In general, the bands stained with the MAb to the activated EGF receptor are less intense than those stained with MAb 528, probably because only a subset of all bindable EGF receptors are phosphorylated (compare Figures 9 and 10) . As with MAb 528, the A431 purified EGF receptor preparation analyzed with the MAb to the activated receptor shows a distinct band at -170 KD under EGF stimulation. The addition of ATP caused an upward MW shift of the EGF receptor band, presumably due to receptor autophosphorylation. The various degrees of receptor phosphorylation (singly vs multiply phosphorylated) probably cause changes in receptor charge and size; therefore, the band representing the phosphorylated receptor is wider or more diffuse.
Effect of H202 on Antibody Binding to the EGF Receptor
Initial studies were conducted using an avidin-peroxidase complex to detect binding of the biotinylated anti-IgG to MAb 528, which recognizes the binding domain of the human EGF receptor. When sections were treated with H202 to abolish endogenous peroxidase activity before incubation with the first antibody, the EGF binding domain of the EGF receptor failed to immunostain with MAb 528. However, when tissue sections were treated with Hz02 after binding of MAb 528, immunostaining resulted, indicating that the EGF receptor binding domain could not tolerate a strong oxidizing agent. As an alternative approach, substitution of an avidin-alkaline phosphatase complex for the avidin-peroxidase complex was 
Discussion
In this study we have demonstrated immunostaining of the binding domain of EGF receptors as well as activated, tyrosine-phosphorylated EGF receptors, in first-and third-trimester human placental samples. In first-trimester placental samples, staining of the EGF receptor binding domain was demonstrated on the entire circumference of a subset of the cytotrophoblast cells or all but the domain facing the basement membrane, as has been described by others (18) (19) (20) . In addition, the microvillous border of syncytiotrophoblast cells was also heavily labeled. These findings are in contrast to the study of Kawagoe et al. (18) which also used MAb 528, in which little or no staining of the cytotrophoblast cell surface domain facing the basement membrane was shown and weak staining of the cytotrophoblastic cell surface domain facing the syncytiotrophoblast. "Diffuse linear, or sometimes patchy" immunostaining of the syncytiotrophoblastic cell surface in frozen sections of placental tissues was also reported. In this study, intense staining of the plasma membranes of both trophoblast cell layers was shown, as well as two additional patterns of staining (Figure 1 ). The cytotrophoblast cell surface of some villi stained intensely for the EGF receptor binding domain, whereas the microvillous bor- Figure 1 ) suggests that adjacent syncytia were staining differently. This new finding poses interesting questions as to the uniqueness of individual syncytia and to the degree to which the activities of adjacent syncytia are synchronized. Staining of first-trimester placental samples with the MAb to the activated EGF receptor showed a staining pattern comparable to that with MAb 528, inasmuch as there was intense staining of the cytoplasm and microvillous border of the syncytiotrophoblast, which faces maternal blood. However, staining ofthe cytotrophoblast plasma membrane was not apparent, nor was there intense staining of the syncytiotrophoblast plasma membrane facing maternal blood. Since the relative avidities of the two MAb are not known, staining intensities should be considered to give an indication of the physiological state and should not be considered quantitative.
These data are consistent with the model that EGF receptors on the cytotrophoblast plasma membrane bind EGF or TGF-a, are activated (phosphorylated), and undergo internalization. This would account for both the intense staining of plasma membranes with the MAb to the binding domain of the human EGF receptor and the cytoplasmic staining with the MAb to the activated EGF receptor. Similarly, EGF receptors on the plasma membrane of the syncytiotrophoblast may be binding EGF present in the maternal circulation. Again, heavy staining of the binding domain ofthe human EGF receptor at the microvillous border of plasma membrane would be expected with staining of the syncytiotrophoblast cytoplasm by the MAb to the activated EGF receptor.
Immunostaining with MAb 528 of term placenta collected at elective cesarean sections revealed occasional staining over the cytotrophoblast cell layer, little to no staining of the syncytiotrophoblast, and intense staining of fetal connective tissue. At this point in gestation the cytotrophoblast has thinned, reflecting its diminished role and the absence of significant growth of the placental mass during the third trimester. The absence of staining for the EGF receptor binding domain would be consistent with the lack of need for %Ea stimulation of placental growth as well as EGFstimulated secretion of hCG (11) (12) (13) (14) (15) (16) and progesterone (17) at term. The absence of significant staining of the trophoblast cell layers with the MAb to the activated EGF receptor is also consistent with this hypothesis.
It is of interest to note that in this study, light to moderate staining of fetal connective tissue was demonstrated with the MAb to the binding domain of the EGF receptor. Bulmer et al. (19) also demonstrated faint staining of fetal connective tissue with a different MAb to the EGF receptor, and Chegini and Rao (24) demonstrated connective tissue labeling using an autoradiographic approach. As noted, staining of connective tissue in both fmt-trimester and term placental tissues was demonstrated with the MAb to the activated EGF receptor, indicating that the receptors localized are functional. The increased staining apparent in term placentas suggests that the increase in numbers of EGF receptors across gestation shown by radioreceptor assays are due to an increase in connective tissue, rather than epithelial, receptors for EGF (9).
This study constitutes the first cytologic demonstration of both the binding domain of human EGF receptors as well as the tyrosinephosphorylated EGF receptors in human placental tissues. The demonstration of the binding domain on the cytotrophoblast cell surfaces suggests that the receptors are synthesized by the cytotrophoblast. The absence of activated receptors on the cytotrophoblast plasma membranes suggests that the receptors may not be activated at this site. In this context, the different staining patterns in this study, as well as in the study of Kawagoe et al. (18) , are perhaps best viewed as points on a continuum, starting with EGF receptor synthesis by the cytotrophoblast, followed by transfer to the syncytiotrophoblast at the time of cytotrophoblast cell fusion, and ending with binding of maternal EGF to EGF receptors on the microvillous border of the syncytiotrophoblast facing maternal blood. This does not rule out the possibility that the syncytiotrophoblast is also capable of de novo synthesis of EGF receptors, as Alsat et al. (25) have demonstrated an increase in EGF receptor gene expression in syncytiotrophoblasts, as compared to cytotrophoblasts, in placental cells in culture. De novo synthesis of EGF receptors and intemalization of EGF receptors on syncytiotrophoblast plasma membranes would both account for the staining of the syncytiotrophoblast cytoplasm observed.
Given the limits of sensitivity of the immunocytochemical approach, it also does not rule out the possibility that small numbers of EGF receptors on the cytotrophoblast not detectable by this approach are activated by the binding of EGF or 'EFa and play a role in regulation ofplacental growth and differentiation. Hofmann et al. (1) reported intense staining of EGF over the syncytiotrophoblast layer of first-trimester placenta with light to moderate staining of the cytotrophoblast, both of which decreased as pregnancy progressed. However, Bissonnette and colleagues (2) reported low levels of EGF and EGF mRNA throughout gestation and high levels of TGFa and %Fa mRNA. It is not clear whether these growth factors interact with the EGF receptor in a paracrine or autocrine manner. To address this latter issue, a necessary first step will be to combine in situ hybridization histochemistry for EGF and E Fa with immunostaining of the EGF receptor binding domain, as well as the activated receptor, to determine their spatial relationship throughout gestation. This information would increase our understanding of the role played by these mitogens in placental growth and differentiation.
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